Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levulan PDT after Cryotherapy for Actinic Keratosis
NCT02239679Phase 2Completed
- Sponsor
- DUSA Pharmaceuticals
- Start
- Sep 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aminolevulinic acid 10% gel in actinic keratosis (AK) (3 arms), sponsored by DUSA Pharmaceuticals. Primary endpoint: Total Number of AKs in Treatment Area at Week 52. Started Sep 2014; status: completed.
02
Drugs
aminolevulinic acid 10% gel
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02239679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02239679.